Ear, nose and throat manifestations of Behçet's disease: A review

Journal of Laryngology and Otology

Volumn 122, Issue 12, 2008, Pages 1279-1283

  Webb, C J ^a   Moots, R J ^b   Swift, A C ^b  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

Beh et's disease; Otolaryngology; Otorhinolaryngological diseases

Indexed keywords

ANTICOAGULANT AGENT; COLCHICINE; CORTICOSTEROID; INFLIXIMAB; STEROID; TETRACYCLINE; THALIDOMIDE; TRIAMCINOLONE;

AWARENESS; BEHCET DISEASE; CLINICAL FEATURE; DRUG MEGADOSE; EAR NOSE THROAT DISEASE; EPIDEMIOLOGICAL DATA; HEARING LOSS; HUMAN; LOW DRUG DOSE; MEDLINE; MOUTH CAVITY; MOUTH ULCER; MUCOSA INFLAMMATION; PATHOGENESIS; PUBLICATION; PURE TONE AUDIOMETRY; REVIEW; RHEUMATOID ARTHRITIS; SKIN DISEASE; THROMBOSIS; VESTIBULAR TEST;

BEHCET SYNDROME; FEMALE; HLA-B ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; ORAL ULCER; OTORHINOLARYNGOLOGIC DISEASES; RESPIRATION DISORDERS; STEROIDS; ULCER;

EID: 57049151785     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215108002703     Document Type: Review

References (27)

1. Dilsen N. History and development of Behçet's disease. Rev Rhum Engl Ed 1996;63:512-19
2. Verity CH, Wallace GR, Vaughan RW, Stanford MR. Behçet's disease: from Hippocrates to the third millennium. Br J Ophthalmol 2003;87:1175-83
3. Behçet's disease. http://www.emedicine.com/DERM/topic49.htm [22 August 2005]
4. Bang D, Lee JH, Lee E-S, Lee S, Choi JS, Kim YK et al. Epidemiologic and clinical survey of Behçet's disease in Korea: the first multicenter study. J Korean Med Sci 2001;16:615-18
5. Mege JL, Dilsen N, Sanguedolce V, Gul A, Bongrand P, Roux H et al. Overproduction of monocyte derived TNF, interleukin (IL) 6, IL 8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993;20:1544-9
6. Accardo-Palumbo A, Triolo G, Carbone MC, Ferrante A, Ciccia F, Giardina E et al. Polymorphonuclear leukocyte myeloperoxidase levels in Behçet's disease. Clin Exp Rheumatol 2000;18:495-8
7. Gul A, Inanc M, Ocal L, Aral O, Konice M. Familial aggregation of Behçet's disease in Turkey. Ann Rheum Dis 2000;59:622-5
8. Fresko I, Soy M, Hamurydan V, Yurdakul S, Yavuz S, Turner Z et al. Genetic anticipation in Behçet's syndrome. Ann Rheum Dis 1998;57:45-8
9. Mingari MC, Moretta A, Moretta L. Regulation of KIR expression in human T cells; a safety mechanism that may impair protective T cell responses. Immunol Today 1998;19:153-7
10. Soylu L, Aydogan B, Soylu M, Ozsahinoglu C. Hearing loss in Behçet's disease. Ann Otol Rhinol Laryngol 1995; 104:864-7
11. Gemignani G, Berrettini S, Bruschini P, Sellari-Francheschini S, Fusari P, Piragine F et al. Hearing and vestibular disturbance in Behçet's syndrome. Ann Otol Rhinol Laryngol 1991;100:459-63
12. Evereklioglu C, Cokkeser Y, Doganay S, Er H, Kizilay A. Audio-vestibular evaluation in patients with Behçet's syndrome. J Laryngol Otol 2001;115:704-8
13. 'Martins HM, Santos S, Lourenco JF, Araujo JA. Destructive sinusopathy and middle ear involvement in Behçet's syndrome. A case report. Adv Exp Med Biol 2003;528:473-5
14. Shahram F, Assadi K, Davatchi F, Nadji A, Jamshidi A, Chams C et al. Chronology of clinical manifestations in Behçet's disease. Analysis of 4024 cases. Adv Exp Med Biol 2003;528:85-9
15. Papadimitraki ED, Kyrmizakis DE, Kritikos I, Boumpas DT. Ear-nose-throat manifestations of autoimmune rheumatic diseases. Clin Exp Rheumatol 2004;22:485-94
16. Nonomura N, Nishiwaki C, Hasegawa S, Ikarashi F, Nakano Y. A case of pharyngolaryngeal stenosis in Behçet's disease. Auris Nasus Larynx 1992;19:55-61
17. Brookes GB. Pharyngeal stenosis in Behçet's disease. The first reported case. Arch Otolaryngol 1983;109:338-40
18. Hamza M, Ferjaoui M, Elleuch M, Bergaoui N, Souilem J, Atallah M et al. Pharyngeal stenosis in a case of Behçet's disease [in French]. Ann Otolaryngol Chir Cervicofac 1985;102:465-7
19. Hamza M. Pharyngeal stenosis in Behçet's disease. Clin Exp Rheumatol 1988;6:139-40
20. Bang D. Clinical spectrum of Behçet's disease. J Dermatol 2001;28:610-13
21. Yazici H, Tuzun Y, Pazarli H, Yalcin B, Yurdakul S, Muftuoglu A. The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey. J Rheumatol 1980;7:206-10
22. Davies PG, Fordham JN, Kirwan JR, Barnes CG, Dinning WJ. The pathergy test and Behçet's syndrome in Britain. Ann Rheum Dis 1984;43:70-3
23. Yazici H, Chamberlain MA, Tuzun Y, Yurdakul S, Muftuoglu A. A comparative study of the pathergy reaction among Turkish and British patients with Behçet's disease. Ann Rheum Dis 1984;43:74-5
24. International Study Group for Behçet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990;335:1078-80
25. Mizushima Y, Inaba G, Mimura Y, Ohno S. Diagnostic criteria for Behçet's disease in 1987 and guidelines for treating Behçet's disease. Saishin Igaku 1988;43:391-3 [in English, later amended in Japanese]
26. Rhee SH, Kim YB, Lee ES. Comparison of Behçet's disease and recurrent aphthous ulcer according to characteristics of gastrointestinal symptoms. J Korean Med Sci 2005;20:971-6
27. Estrach C, Mpofu S, Moots RJ. Behçet's syndrome: response to infliximab after failure of etanercept. Rheumatology 2002;41:1213- 14